Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 289
of 15Next
1:

The quality of antimalarials available in Yemen.

Abdo-Rabbo A, Bassili A, Atta H.

Malar J. 2005 Jun 29;4:28.

PMID: 15987508 [PubMed - indexed for MEDLINE]

2:

Quality evaluation of chloroquine, quinine, sulfadoxine-pyrimethamine and proguanil formulations sold on the market in East Congo DR.

Atemnkeng MA, Chimanuka B, Plaizier-Vercammen J.

J Clin Pharm Ther. 2007 Apr;32(2):123-32.

PMID: 17381662 [PubMed - indexed for MEDLINE]

3:

Antimalarial drug quality in Africa.

Amin AA, Kokwaro GO.

J Clin Pharm Ther. 2007 Oct;32(5):429-40. Review.

PMID: 17875107 [PubMed - indexed for MEDLINE]

4:

The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector.

Amin AA, Snow RW, Kokwaro GO.

J Clin Pharm Ther. 2005 Dec;30(6):559-65.

PMID: 16336288 [PubMed - indexed for MEDLINE]

5:

Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania.

Minzi OM, Moshi MJ, Hipolite D, Massele AY, Tomson G, Ericsson O, Gustafsson LL.

J Clin Pharm Ther. 2003 Apr;28(2):117-22.

PMID: 12713608 [PubMed - indexed for MEDLINE]

6:

Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials.

Gaudiano MC, Di Maggio A, Cocchieri E, Antoniella E, Bertocchi P, Alimonti S, Valvo L.

Malar J. 2007 Feb 22;6:22.

PMID: 17316432 [PubMed - indexed for MEDLINE]

7:

Quality of oral and parenteral chloroquine in Kampala.

Ogwal-Okeng JW, Okello DO, Odyek O.

East Afr Med J. 1998 Dec;75(12):692-4.

PMID: 10065207 [PubMed - indexed for MEDLINE]

8:

A nationwide survey of the quality of antimalarials in retail outlets in Tanzania.

Kaur H, Goodman C, Thompson E, Thompson KA, Masanja I, Kachur SP, Abdulla S.

PLoS ONE. 2008;3(10):e3403. Epub 2008 Oct 15.

PMID: 18923672 [PubMed - in process]

9:

The chemical and pharmaceutical equivalence of sulphadoxine/pyrimethamine tablets sold on the Tanzanian market.

Hebron Y, Tettey JN, Pournamdari M, Watson DG.

J Clin Pharm Ther. 2005 Dec;30(6):575-81.

PMID: 16336290 [PubMed - indexed for MEDLINE]

10:

Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa.

Mehta U, Durrheim D, Mabuza A, Blumberg L, Allen E, Barnes KI.

Drug Saf. 2007;30(10):899-910.

PMID: 17867727 [PubMed - indexed for MEDLINE]

11:

Chloroquine in the Ugandan market fails quality test: a pharmacovigilance study.

Ogwal-Okeng JW, Owino E, Obua C.

Afr Health Sci. 2003 Apr;3(1):2-6.

PMID: 12789081 [PubMed - indexed for MEDLINE]

12:

Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania.

Hetzel MW, Msechu JJ, Goodman C, Lengeler C, Obrist B, Kachur SP, Makemba A, Nathan R, Schulze A, Mshinda H.

Malar J. 2006 Nov 14;5:109.

PMID: 17105662 [PubMed - indexed for MEDLINE]

13:

In vitro evaluation of marketed antimalarial chloroquine phosphate tablets.

Patel AK, Prajapati BG, Moria RS, Patel CN.

J Vector Borne Dis. 2005 Dec;42(4):147-50.

PMID: 16457384 [PubMed - indexed for MEDLINE]

14:

Strengthening of national capacity in implementation of antimalarial drug quality assurance in Thailand.

Vijaykadga S, Cholpol S, Sitthimongkol S, Pawaphutanan A, Pinyoratanachot A, Rojanawatsirivet C, Kovithvattanapong R, Thimasarn K.

Southeast Asian J Trop Med Public Health. 2006;37 Suppl 3:5-10.

PMID: 17547041 [PubMed - indexed for MEDLINE]

16:

Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.

Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA, Mills A, Bloland P.

Trop Med Int Health. 2004 Jun;9(6):655-63.

PMID: 15189455 [PubMed - indexed for MEDLINE]

17:

Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.

Basco LK, Ngane VF, Ndounga M, Same-Ekobo A, Youmba JC, Abodo RT, Soula G.

Am J Trop Med Hyg. 2006 Sep;75(3):388-95.

PMID: 16968911 [PubMed - indexed for MEDLINE]

18:

Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication.

Basco LK.

Am J Trop Med Hyg. 2004 Mar;70(3):245-50.

PMID: 15031511 [PubMed - indexed for MEDLINE]

19:

Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.

Nsimba B, Jafari-Guemouri S, Malonga DA, Mouata AM, Kiori J, Louya F, Yocka D, Malanda M, Durand R, Le Bras J.

Trop Med Int Health. 2005 Oct;10(10):1030-7.

PMID: 16185238 [PubMed - indexed for MEDLINE]

20:

Physicochemical equivalence of chloroquine phosphate tablets.

Bamiro OA, Odeniyi MA, Idowu OB, Jaiyeoba KT.

Afr J Med Med Sci. 2004 Dec;33(4):371-5.

PMID: 15977447 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 289
of 15Next